AU2022349697A1 - Synthetic production of circular dna vectors - Google Patents

Synthetic production of circular dna vectors Download PDF

Info

Publication number
AU2022349697A1
AU2022349697A1 AU2022349697A AU2022349697A AU2022349697A1 AU 2022349697 A1 AU2022349697 A1 AU 2022349697A1 AU 2022349697 A AU2022349697 A AU 2022349697A AU 2022349697 A AU2022349697 A AU 2022349697A AU 2022349697 A1 AU2022349697 A1 AU 2022349697A1
Authority
AU
Australia
Prior art keywords
therapeutic
dna
linear
sequence
dna vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022349697A
Other languages
English (en)
Inventor
Meisam BAKHSHAYESH
Eliza DORNBUSH
Eileen HIGHAM
Jin Huh
Jodi KENNEDY
Jose Lora
Anne MAGUIRE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aldevron LLC
Original Assignee
Aldevron LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aldevron LLC filed Critical Aldevron LLC
Publication of AU2022349697A1 publication Critical patent/AU2022349697A1/en
Assigned to ALDEVRON, LLC reassignment ALDEVRON, LLC Request for Assignment Assignors: Intergalactic Therapeutics, Inc.
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2022349697A 2021-09-27 2022-09-27 Synthetic production of circular dna vectors Pending AU2022349697A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163248801P 2021-09-27 2021-09-27
US63/248,801 2021-09-27
PCT/US2022/077108 WO2023049937A2 (en) 2021-09-27 2022-09-27 Synthetic production of circular dna vectors

Publications (1)

Publication Number Publication Date
AU2022349697A1 true AU2022349697A1 (en) 2024-05-16

Family

ID=85721330

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022349697A Pending AU2022349697A1 (en) 2021-09-27 2022-09-27 Synthetic production of circular dna vectors

Country Status (10)

Country Link
US (1) US20240409975A1 (cg-RX-API-DMAC10.html)
EP (1) EP4408994A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024535917A (cg-RX-API-DMAC10.html)
KR (1) KR20240126447A (cg-RX-API-DMAC10.html)
CN (1) CN118679248A (cg-RX-API-DMAC10.html)
AU (1) AU2022349697A1 (cg-RX-API-DMAC10.html)
CA (1) CA3233230A1 (cg-RX-API-DMAC10.html)
IL (1) IL311778A (cg-RX-API-DMAC10.html)
MX (1) MX2024003870A (cg-RX-API-DMAC10.html)
WO (1) WO2023049937A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026515898A (ja) * 2023-04-28 2026-05-19 ユニバーシティ オブ メリーランド、バルティモア カウンティ インビトロでスーパーコイル状の環状dnaを作製する方法
WO2025007021A2 (en) * 2023-06-30 2025-01-02 Novel Biotechnology Inc. Cell-free replication of a nucleic acid construct
WO2025175112A1 (en) * 2024-02-16 2025-08-21 University Of Maryland, Baltimore County Method for generating circular dna using heteroduplex thermostable ligation assembly of precursors produced by rolling circle amplification

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340264T1 (de) * 2003-06-10 2006-10-15 Mologen Ag Zirkuläres expressionskonstrukt für gentherapeutische anwendungen
WO2006063355A2 (en) * 2004-12-11 2006-06-15 Cytogenix , Inc. Cell free biosynthesis of high-quality nucleic acid and uses thereof
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
GB201321123D0 (en) * 2013-11-29 2014-01-15 Linea Ab Q Amplification of circular molecules
JP7058502B2 (ja) * 2014-04-11 2022-04-22 レッドボールト バイオサイエンシズ エルピー ゲノム適用および治療適用のための、核酸分子のクローン複製および増幅のためのシステムおよび方法
FR3032447B1 (fr) * 2015-02-10 2020-02-21 Universite Des Sciences Et Technologies De Lille-Lille 1 Procede de fabrication de vecteurs d'adn a partir de briques moleculaires contenant des sequences d'interet
JP7335224B2 (ja) * 2017-07-18 2023-08-29 ジェノヴィー エービー 全長t細胞受容体オープンリーディングフレームの迅速な組立ておよび多様化のための二成分ベクターライブラリシステム
EP3987043A4 (en) * 2019-06-21 2023-07-19 Asklepios Biopharmaceutical, Inc. PRODUCTION OF VECTORS USING THE PHAGEN REPLICATION ORIGIN
WO2021055760A1 (en) * 2019-09-18 2021-03-25 Intergalactic Therapeutics, Inc. Synthetic dna vectors and methods of use

Also Published As

Publication number Publication date
US20240409975A1 (en) 2024-12-12
CA3233230A1 (en) 2023-03-30
JP2024535917A (ja) 2024-10-02
WO2023049937A3 (en) 2023-08-10
MX2024003870A (es) 2024-09-11
IL311778A (en) 2024-05-01
CN118679248A (zh) 2024-09-20
KR20240126447A (ko) 2024-08-20
WO2023049937A2 (en) 2023-03-30
EP4408994A4 (en) 2025-04-09
EP4408994A2 (en) 2024-08-07

Similar Documents

Publication Publication Date Title
US20240409975A1 (en) Synthetic production of circular dna vectors
US9890391B2 (en) RNA vector with an open reading frame, an albumin 3′-UTR, and a histone stem loop
CN113454232B (zh) 封闭端dna(cedna)产生中对rep蛋白活性的调节
EP1853712B1 (fr) Vecteurs d'expression stable et de longue duree de sirna et leurs applications
AU2020233404A1 (en) Circular polyribonucleotides and pharmaceutical compositions thereof
TW202411426A (zh) 經工程化的2類v型crispr系統
CA3186872A1 (en) Baculovirus expression systems
US20240376468A1 (en) CIRCULAR GUIDE RNAs FOR CRISPR/CAS EDITING SYSTEMS
JP2024511206A (ja) 免疫原性組成物
CN101287838B (zh) 狂犬病病毒组合物和方法
EP4165198A1 (en) Tandem anellovirus constructs
WO2018139637A1 (ja) 核酸封入aav中空粒子
CA3245458A1 (en) COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN TRANSLATION FROM RECOMBED CIRCULAR RNA
CN118489008A (zh) 封闭端dna载体的可扩展且高纯度无细胞合成
US20250066809A1 (en) Production of gene therapy vector in engineered bacteria
CN120981575A (zh) 细胞中的基因组插入
KR20230044631A (ko) 자가 증폭이 가능하고 단백질을 합성하는 mRNA/DNA 하이브리드 시스템 및 이의 조성물
WO2025011529A2 (en) Circular rna vaccines for seasonal flu and methods of uses
US20250018024A1 (en) Compositions and methods for protein expression with rna
WO2025081042A1 (en) Nickase-retron template-based precision editing system and methods of use
CA3211307A1 (en) Utrapure minivectors for gene therapy
WO2025171168A1 (en) Methods and systems for rna encapsulation to increase rna stability and translation efficiency
KR20250021327A (ko) 간 효소 발현의 보충
CN121801903A (zh) 一种自组装自复制rna系统及其应用

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ALDEVRON, LLC

Free format text: FORMER APPLICANT(S): INTERGALACTIC THERAPEUTICS, INC.